Empacoza-empagliflozin

  • Empacoza-empagliflozin 1
  • Empacoza-empagliflozin 2
Product Description

empagliflozin.............................................. 10 mg

empagliflozin.............................................. 25 mg

Therapeutic Indications

● Type 2 Diabetes Mellitus

○ Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes

○ Also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease

● Heart Failure

○ Indicated to reduce the risk of cardiovascular death plus hospitalization in adults with heart failure (HF)

Dosage and Administration

● 10 mg PO qDay

● May increase to 25 mg/day if needed and tolerated

Pharmacological Properties

Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney

Packaging

Empacoza 10mg Tablets: Box containing 3 blisters of 10 tablets each

Packaging

Empacoza 25mg Tablets: Box containing 3 blisters of 10 tablets each

Read more Show less

Zeta Pharma

  • EG
  • 2019
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Association/Government
Contract Service
Distributor/Import Export
OTC
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Finished Formulation products Distributor/Buyer
Nutraceuticals
Pharmaceutical Company (generic finished products)
Regulatory Affairs
View company profile
Categories
more categories Show less

Zeta Pharma

  • EG
  • 2019
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Association/Government
Contract Service
Distributor/Import Export
OTC
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Finished Formulation products Distributor/Buyer
Nutraceuticals
Pharmaceutical Company (generic finished products)
Regulatory Affairs
View company profile

More Products from Zeta Pharma (2)

  • Elimbosis-Apixaban

    Product Elimbosis-Apixaban

    Composition Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 5 mg Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 2.5 mg Therapeutic Indications ● Stroke Prophylaxis with Atrial Fibrillation ● Postoperative Prophylaxis of DVT/PE -DVT or PE Treatm...
  • Nexicure mups-Esomeprazole

    Product Nexicure mups-Esomeprazole

    Each Nexicure 40mg Film Coated MUPS tablet contains: Esomeprazole ...... 40 mg Each Nexicure 20mg Film Coated MUPS tablet contains: ......................................... 20 mg Therapeutic Indications ● Gastroesophageal reflux disease’ (GERD) ● Erosive reflux oesophagitis. ● Treatment of Zollinger-Ellis...

Zeta Pharma resources (1)

  • Zeta Pharma Company Profile

    Brochure Zeta Pharma Company Profile

     ZETA PHARMA® is the leading branded generic from Egypt

    ZETA PHARMA®, established in 2010, brings significant value to the  pharmaceutical industry in Egypt, Africa, Middle East and CIS regions.

    ZETA PHARMA® is the fastest-growing company in the top 100 Egyptian pharmaceutical companies during the last 4 years with CAGR % 112 ( IQVIA.)

    ZETA PHARMA® boasts a state-of-the-art manufacturing facility built to WHO cGMP standards.

    ZETA PHARMA®, in a groundbreaking partnership with the European Bank for Reconstruction and Development (EBRD), has embarked on an ambitious project to secure EMA accreditation. This endeavor underscores our unwavering commitment to excellence and innovation, setting new standards in the pharmaceutical industry.

    ZETA PHARMA®, offer advanced manufacturing meets cutting-edge pharmaceutical solutions, empowering health and wellness across the globe...

Recommended Products